[1] |
Liu Yuanxiang, Liang Yuan, Zhao Xinrong, Sun Yujuan, Ma Lin, Xu Zigang.
Janus kinase inhibitors for the treatment of five children with severe alopecia areata
[J]. Chinese Journal of Dermatology, 2023, 56(9): 849-852.
|
[2] |
Wang Junxia, Guo Weinan, Chen Hui, Hao Junfeng, Li Bing, Wei Jingyi, Zhao Tao.
Efficacy of autologous fat grafting in the treatment of 40 cases of stable linear scleroderma: a retrospective analysis
[J]. Chinese Journal of Dermatology, 2023, 56(8): 762-765.
|
[3] |
Jiang Xiaoyan, Gao Min, Zhang Xiaoyan, Liu Ningyuan.
Interleukin-17 and interleukin-23 inhibitors in the treatment of pustular psoriasis
[J]. Chinese Journal of Dermatology, 2023, 56(7): 689-692.
|
[4] |
Yang Nali, Xu Qiuyang, Wu Hanwen, Ye Yahui, Zhu Jiling, Liu Jingjing, Li Zhiming.
Efficacy and safety of omalizumab in the treatment of chronic urticaria: a retrospective analysis
[J]. Chinese Journal of Dermatology, 2023, 56(6): 518-524.
|
[5] |
Su Chang, Sui Xiuli, Liu Ruiling, Cao Yiqun, Jiang Hong, Yan Cairong, Wang Huiping, Qi Yuqing.
Omalizumab for the treatment of 74 patients with chronic spontaneous urticaria accompanied by other allergic diseases: a clinical analysis
[J]. Chinese Journal of Dermatology, 2023, 56(6): 512-517.
|
[6] |
Wang Xin, Liu Lijuan, Li Linfeng.
Clinical features of chronic spontaneous urticaria in China: results from a hospital-based multicenter epidemiological survey
[J]. Chinese Journal of Dermatology, 2023, 56(6): 525-530.
|
[7] |
Li Liqiao, Peng Cong, Chen Xiang, Li Jie.
Efficacy of omalizumab in the treatment of chronic urticaria patients with poor response to antihistamines: a single-center retrospective study
[J]. Chinese Journal of Dermatology, 2023, 56(6): 504-511.
|
[8] |
Chen Qiquan, Yang Xianjie, Gu Heng, Xu Jinhua, Hao Fei, Yao Xu, Song Zhiqiang.
Construction of “Expert consensus on diagnosis and treatment of chronic inducible urticaria in China (2023)” based on the Delphi method
[J]. Chinese Journal of Dermatology, 2023, 56(6): 534-539.
|
[9] |
Guo Weinan, Wang Junxia, Chen Hui, Hao Junfeng, Li Bing, Wei Jingyi, Zhao Tao.
Clinical efficacy of autologous adipose-derived stem cell gel grafting in the treatment of depressed acne scars
[J]. Chinese Journal of Dermatology, 2023, 0(3): 20210867-e20210867.
|
[10] |
Zhou Jian, Yu Chen, Wang Gang.
Clinical efficacy and safety of secukinumab in the treatment of 13 cases of refractory localized pustular psoriasis
[J]. Chinese Journal of Dermatology, 2023, 56(3): 247-251.
|
[11] |
Hu Kun, Yang Jing, Wang Qiaolin, Chen Junchen, Zhang Mi, Zhu Wu, Zhang Bin, Dou Guanshen, Wendong Chen, Kuang Yehong.
Real-world short-term treatment effects of Ixekizumab in Chinese patients with psoriasis: a single-center retrospective study
[J]. Chinese Journal of Dermatology, 2023, 56(3): 210-215.
|
[12] |
Wan Li, Hu Bin, Luo Hongyu, Fang Meizhen, Han Lijuan, Chen Qiang, Zhou Xiaoyong, Chen Liuqing, Chen Jinbo.
Clinical characteristics and treatment of eight cases of pemphigus/bullous pemphigoid complicated by herpes simplex virus infection
[J]. Chinese Journal of Dermatology, 2023, 56(3): 229-233.
|
[13] |
Hu Yu, Gu Heng, Chen Kun.
Disease burden and unmet medical needs in Chinese patients with moderate-to-severe psoriasis: a systematic review
[J]. Chinese Journal of Dermatology, 2023, 56(10): 965-972.
|
[14] |
Zheng Jiayuan, Yu Bingqian, Chen Xianxia, Luo Zhicheng.
Characteristics of pruritus in adult patients with psoriasis vulgaris and its effect on quality of life
[J]. Chinese Journal of Dermatology, 2022, 55(9): 790-794.
|
[15] |
Gao Zirui, Zhao Pei, Dou Yuanqing, Liu Ping, Zhang Jianzhong.
Efficacy and safety of dupilumab in the treatment of adult prurigo nodularis
[J]. Chinese Journal of Dermatology, 2022, 55(7): 562-565.
|